MASP-1 of the complement system alters fibrinolytic behaviour of blood clots
Lorenz Jenny(University of Bern), Verena Schroeder(University of Bern), Julie Brogaard Larsen(Aarhus University), Péter Gál(University of Pavol Jozef Šafárik), József Dobó(HUN-REN Research Centre for Natural Sciences), Danilo Noser(University of Bern), Gábor Pál(Eötvös Loránd University)
Cited by 21
Related Papers
Disseminated intravascular coagulation: epidemiology, biomarkers, and management
|British Journal of Haematology|2021|179
The Structure of MBL-associated Serine Protease-2 Reveals that Identical Substrate Specificities of C1s and MASP-2 are Realized Through Different Sets of Enzyme–Substrate Interactions
|Journal of Molecular Biology|2004|86
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties
|Diabetes and Vascular Disease Research|2012|80
Thrombin: A Pivotal Player in Hemostasis and Beyond
|Seminars in Thrombosis and Hemostasis|2021|80
The Lectin Pathway of the Complement System—Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems
|International Journal of Molecular Sciences|2024|78